Mitochondrial DNA mutations are associated with impaired oxidative phosphorylation and enhanced imatinib response in chronic myeloid leukemia. [PDF]
Pagani IS +25 more
europepmc +1 more source
Reversal of protein chemical aging by enzymatic deglycation. [PDF]
Trabosh N +7 more
europepmc +1 more source
Ponatinib plus asciminib in myeloid blast-phase CML harboring a phased <i>BCR</i>::<i>ABL1</i> Y253H/T315I compound mutation: a case report. [PDF]
Hu Y, Ma H, He X.
europepmc +1 more source
A Case of Duffy-Null-Associated Neutropenia in a Patient With Chronic Myeloid Leukemia. [PDF]
Parekh A, Metzner-Sadurski J.
europepmc +1 more source
Real-World Management of Chronic Myelogenous Leukemia in an Underserved Patient Cohort at a Los Angeles Safety-Net Health System: Tyrosine Kinase Inhibitor Treatment Patterns and Outcomes From 2015 to 2024. [PDF]
Zheng D +4 more
europepmc +1 more source
Clonal and genomic determinants of e1a2 <i>BCR::ABL1</i> chronic myeloid leukemia: A Fi-LMC study. [PDF]
Podvin B +25 more
europepmc +1 more source
Meta-Analysis of Imatinib Resistance in Chronic Myeloid Leukemia due to BIM Gene Deletion and Single Nucleotide Polymorphisms Reveals Ethnic Variations in Prevalence. [PDF]
Bhattarai A +4 more
europepmc +1 more source
Two novel e13a3 variants detected in CML patients and their DNA breakpoint analysis. [PDF]
Liang D +6 more
europepmc +1 more source

